Clinical Characteristics of Aldosterone- and Cortisol-Coproducing Adrenal Adenoma in Primary Aldosteronism

Clinical Characteristics of Aldosterone- and Cortisol-Coproducing Adrenal Adenoma in Primary Aldosteronism

Aldosterone- and cortisol-coproducing adrenal adenoma (A/CPA) cases have been observed in patients with primary aldosteronism (PA). This study investigated the incidence, clinical characteristics, and molecular biological features of patients with A/CPAs. We retrospectively identified 22 A/CPA patie...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lu Tang, Xintao Li, Baojun Wang, Xin Ma, Hongzhao Li, Yu Gao, Liangyou Gu, Wenyuan Nie, Xu Zhang
Format:	Article
Language:	English
Published:	Wiley 2018-01-01
Series:	International Journal of Endocrinology
Online Access:	http://dx.doi.org/10.1155/2018/4920841
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association of Aldosterone and Cortisol with Cardiovascular Risk Factors in Prehypertension Stage
by: Sadiqa Badar Syed, et al.
Published: (2012-01-01)

A Rare Presentation of Primary Hyperparathyroidism with Concurrent Aldosterone-Producing Adrenal Carcinoma
by: Mario Molina-Ayala, et al.
Published: (2015-01-01)

In Silico Analysis of the Gene Expression Patterns between Aldosterone-Producing Adenoma and Nonfunctional Adrenocortical Adenoma
by: Yongfa Dai, et al.
Published: (2021-01-01)

Primary aldosteronism patients with previous cardiovascular and cerebrovascular events have high aldosterone responsiveness to ACTH stimulation
by: Eriko Nakano, et al.
Published: (2024-05-01)

Adrenal (Pro)renin Receptor Expression and Serum Soluble (Pro)renin Receptor Concentration in Primary Aldosteronism
by: Daisuke Watanabe, et al.
Published: (2020-01-01)

Adrenal venous sampling criteria for chemiluminescent enzyme immunoassay as a preferable alternative to radioimmunoassay in primary aldosteronism
by: Kazuki Nakai, et al.
Published: (2024-05-01)

Bone and Mineral Metabolism in Patients with Primary Aldosteronism
by: Luigi Petramala, et al.
Published: (2014-01-01)

Twenty-Four-Hour Urinary Aldosterone Predicts Inappropriate Left Ventricular Mass Index in Patients with Primary Aldosteronism
by: Chi-Sheng Hung, et al.
Published: (2013-01-01)

Aldosteronism and Resistant Hypertension
by: Maria Czarina Acelajado, et al.
Published: (2011-01-01)

Clinical comparison and genetic analysis in pheochromocytoma with primary aldosteronism
by: Xurong Mai, et al.
Published: (2025-02-01)

68Ga-Pentixafor PET/CT for the assessment of therapeutic outcomes following superselective adrenal arterial embolization in patients with primary aldosteronism
by: MengDan Li, et al.
Published: (2025-01-01)

Feasibility of Screening Primary Aldosteronism by Aldosterone-to-Direct Renin Concentration Ratio Derived from Chemiluminescent Immunoassay Measurement: Diagnostic Accuracy and Cutoff Value
by: Tianqi Li, et al.
Published: (2019-01-01)

Changes in kidney function after adrenalectomy in patients with primary aldosteronism
by: Yumi Tomiie, et al.
Published: (2025-02-01)

Mild Adrenal Steroidogenic Defects and ACTH-Dependent Aldosterone Secretion in High Blood Pressure: Preliminary Evidence
by: João Martin Martins, et al.
Published: (2014-01-01)

Suppression of Aldosterone Synthesis and Secretion by Channel Antagonists
by: Keiichi Ikeda, et al.
Published: (2012-01-01)

Pathology and gene mutations of aldosterone-producing lesions
by: Koshiro Nishimoto, et al.
Published: (2023-12-01)

The Value of Adrenal Androgens for Correcting Cortisol Lateralization in Adrenal Venous Sampling in Patients with Normal Cortisol Secretion
by: Wenjing Zhang, et al.
Published: (2019-01-01)

Effect of oral potassium supplementation on urinary potassium excretion and its diagnostic value for primary aldosteronism
by: Ke Zhang, et al.
Published: (2025-12-01)

Endoplasmic Reticulum Chaperon Tauroursodeoxycholic Acid Attenuates Aldosterone-Infused Renal Injury
by: Honglei Guo, et al.
Published: (2016-01-01)

Primary Aldosteronism Associated with Multiple Adrenocortical Micronodules in a Patient with Renal Cell Carcinoma
by: Kazuhito Oba, et al.
Published: (2020-01-01)

Impact of the transition from radioimmunoassay (RIA) to chemiluminescent enzyme immunoassay (CLEIA) for the measurement of plasma aldosterone concentration (PAC) on the diagnosis of primary aldosteronism (PA) via retrospective analyses in Okinawa, Japan
by: Ken-ichiro Honma, et al.
Published: (2024-09-01)

Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome
by: P. Stiefel, et al.
Published: (2011-01-01)

The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling
by: Maricica Pacurari, et al.
Published: (2014-01-01)

Sex Difference in the Association of Osteoporosis and Osteopenia Prevalence in Patients with Adrenal Adenoma and Different Degrees of Cortisol Excess
by: Shoichiro Izawa, et al.
Published: (2022-01-01)

Epigenetic alterations of 11beta-hydroxysteroid dehydrogenase 1 gene in the adipose tissue of patients with primary aldosteronism
by: Yoshimichi Takeda, et al.
Published: (2024-03-01)

Renin-angiotensin-aldosterone system in ISIAH rats with stressinduced arterial hypertension
by: A. D. Dubinina, et al.
Published: (2017-02-01)

Circulating Galectin-3 and Aldosterone for Predicting Atrial Fibrillation Recurrence after Radiofrequency Catheter Ablation
by: Zhong-bao Ruan, et al.
Published: (2022-01-01)

Clinical determinants and prognostic implications of renin and aldosterone in patients with symptomatic heart failure
by: Masatake Kobayashi, et al.
Published: (2020-06-01)

Aldosterone Blockade in Acute Myocardial Infarction: A Systematic Review and Meta-Analysis
by: Qiao Chen, et al.
Published: (2021-01-01)

Relationship between Plasma Aldosterone Levels and Left Ventricular Mass in Hypertensive Africans
by: Adewole Adebiyi, et al.
Published: (2013-01-01)

Erratum to “Angiotensin II, Aldosterone, and Anti-Inflammatory Lymphocytes: Interplay and Therapeutic Opportunities”
by: Daniel Arthur B. Kasal, et al.
Published: (2012-01-01)

Cardiac Hypertrophy and Fibrosis in the Metabolic Syndrome: A Role for Aldosterone and the Mineralocorticoid Receptor
by: Eric E. Essick, et al.
Published: (2011-01-01)

Adrenal aldosterone synthase (CYP11B2) histopathology and its association with disease-induced sudden death: a cross-sectional studyResearch in context
by: Antero Ylänen, et al.
Published: (2025-04-01)

Major Adverse Cardiovascular Events in Primary Aldosteronism After Adrenalectomy or Mineralocorticoid Receptor Antagonist Treatment: A Systematic Review and Meta‐Analysis
by: Chien‐Wei Huang, et al.
Published: (2025-02-01)

Long-Term Use of Aldosterone-Receptor Antagonists in Uncontrolled Hypertension: A Retrospective Analysis
by: Pieter M. Jansen, et al.
Published: (2011-01-01)

Physiological Aldosterone Concentrations Are Associated with Alterations of Lipid Metabolism: Observations from the General Population
by: M. Hannich, et al.
Published: (2018-01-01)

The Renin-Angiotensin-Aldosterone System as a Therapeutic Target in Late Injury Caused by Ischemia-Reperfusion
by: Simón Quetzalcóatl Rodríguez-Lara, et al.
Published: (2018-01-01)

Association Between Uric Acid to High‐Density Lipoprotein Cholesterol Ratio and Kidney Function in Patients With Primary Aldosteronism: A Cross‐Sectional Study
by: Meng‐Bo Wu, et al.
Published: (2025-01-01)

Cross-sectional association between plasma aldosterone concentration and cognitive performance by mini-mental state examination in community dwellers
by: Aketilieke Nusufujiang, et al.
Published: (2025-02-01)

‘I can’t understand why others don’t screen more’: a qualitative study exploring why Australian general practitioners screen for primary aldosteronism
by: Sanne Peters, et al.
Published: (2022-06-01)